お知らせ • May 14
Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026 Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million). お知らせ • Apr 27
Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026 Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026 お知らせ • Apr 09
Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027 Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million.
For 2027, the company expects revenue of $50 - $58 million. お知らせ • Apr 01
Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026 Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026 お知らせ • Mar 31
Grown Rogue International Inc. announced delayed annual 10-K filing On 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. お知らせ • Feb 18
Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026 Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026 お知らせ • Oct 21
Grown Rogue International Inc. to Report Q3, 2025 Results on Nov 11, 2025 Grown Rogue International Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025 お知らせ • Jul 21
Grown Rogue International Inc. to Report Q2, 2025 Results on Aug 12, 2025 Grown Rogue International Inc. announced that they will report Q2, 2025 results After-Market on Aug 12, 2025 お知らせ • May 02
Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025 Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025. お知らせ • Apr 10
Grown Rogue International Inc. to Report Q1, 2025 Results on May 13, 2025 Grown Rogue International Inc. announced that they will report Q1, 2025 results on May 13, 2025 お知らせ • Feb 03
Grown Rogue International Inc. Appoints Josh Rosen as Chief Strategy Officer Grown Rogue International Inc. announced the hiring of Josh Rosen as the Company's new Chief Strategy Officer. As CSO, Josh will be responsible for leading Grown Rogue's capital allocation, business development and communication strategy, all in support of helping the Company execute on its vision to build a national craft cannabis brand. Prior to joining the Company, Josh has held numerous positions in the cannabis industry including Executive Chairman and CEO of 4Front Ventures and Chief Executive Officer of Vireo Growth Inc. Before joining 4Front in cannabis, Josh worked as a private equity portfolio manager, with the family office of John Sperling, who was a prominent drug reform philanthropist, and before that as an investment research analyst, primarily with Credit Suisse. Josh continues to serve as a Managing Partner of Bengal Capital, a cannabis investment and advisory firm. お知らせ • Jun 06
Grown Rogue Receives Licensing Approval Approval with the New Jersey Cannabis Regulatory Commission Grown Rogue International Inc. announced it has received licensing approval with the New Jersey Cannabis Regulatory Commission ("CRC") and closed its first option to acquire 44% of ABCO Garden State, LLC ("ABCO") on May 31, 2024. The transaction details are as follows: Grown Rogue has an option to acquire 70% of ABCO through two options; Option 1 was for 44% and Option 2 is for 26% ABCO has an annual cultivation license with the New Jersey Cannabis Regulatory Commission with local zoning and planning approvals and sufficient power supply Upon receiving licensing approval, the Company purchased Option 1 for USD 1,260,000, which has been paid in cash The Company anticipates exercising Option 2, pending regulatory approval, two years after operations commence. The purchase price for Option 2 is USD 720,000 Grown Rogue has the right to purchase the remaining equity of ABCO at fair market value. お知らせ • Apr 26
Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024 Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024. お知らせ • Mar 03
Grown Rogue International Inc. announced delayed 20-F filing On 03/01/2024, Grown Rogue International Inc. announced that they will be unable to file their next 20-F by the deadline required by the SEC. お知らせ • Jul 14
Grown Rogue International Inc. announced that it has received $5 million in funding from Mindset Capital On July 13, 2023, Grown Rogue International Inc. closed the transaction. The transaction was led by retuning investor, Mindset Capital. Additionally, on closing, the company issued to the subscribers under the offering an aggregate of 13,737,500 common share purchase warrants. お知らせ • Jul 07
Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023 Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023. お知らせ • Jul 06
Grown Rogue International Inc. announced that it expects to receive $5 million in funding Grown Rogue International Inc. announced a non-brokered private placement of unsecured convertible debentures with an aggregate principal amount of up to $5,000,000 on July 4, 2023. Each subscriber under the offering shall receive one-half of one common share purchase warrant for each CAD 0.24 ($0.18) of principal amount subscribed. The debentures will mature four years from the closing date, bear interest at a rate equal to 9% per annum, payable in united states currency on the last business day of the month following the end of each calendar quarter and are convertible as set forth below into common shares of the company. The debenture holders will be entitled, at their option, to convert, at any time on or prior to the maturity date, the outstanding Principal Amount and accrued interest into shares at a price per share equal to CAD 0.24 ($0.18). The company may elect to prepay the principal amount together with any interest thereon prior to the maturity date upon providing 30 days’ notice to the debenture holder. Each full Warrant will be exercisable into one share at an exercise price of CAD 0.28 ($0.21) for a period of three years from the closing date and are subject to an acceleration clause that in the event that the shares close at or above CAD 0.40 ($0.30) per share on the Canadian Securities Exchange for ten consecutive trading days, the warrant expiry date shall accelerate to 90 days following notice of the acceleration event. The offering is expected to close in multiple tranches within 30 days, with the first closing occurring on or about July 14, 2023. The debentures, the warrants as well as the underlying shares, will be subject to a statutory hold period for a period of four months and one day from the closing date. The company may, at its option, increase the offering by an additional $1,000,000 for gross proceeds of up to $6,000,000.